Atrium Innovations.

ATB-T

0.00
0.00 (0.00%)
This company is not ACTIVE.

Analysis and Opinions about ATB-T

Signal
Opinion
Expert
SELL
SELL
December 24, 2013

(Market Call Minute) Tender your shares. Gov’t may be reluctant to see this one go.

Atrium Innovations. (ATB-T)
December 24, 2013

(Market Call Minute) Tender your shares. Gov’t may be reluctant to see this one go.

Jason Donville
President & CEO, Donville Kent Asset Management
Price
$24.270
Owned
Unknown
PAST TOP PICK
PAST TOP PICK
November 22, 2013

(A Top Pick Nov 28/12. Up 9.9%.) 5.75% bond maturing August 31/18.

Atrium Innovations. (ATB-T)
November 22, 2013

(A Top Pick Nov 28/12. Up 9.9%.) 5.75% bond maturing August 31/18.

Joey Mack
Director, Fixed Income, ScotiaCapital
Price
$18.690
Owned
No
HOLD
HOLD
April 10, 2013

(Market Call Minute.) The negative on this is that they are big in Europe and the positive is that there is lots of consolidation in the industry.

(Market Call Minute.) The negative on this is that they are big in Europe and the positive is that there is lots of consolidation in the industry.

Norman Levine
Managing Director, Portfolio Management Corp
Price
$12.400
Owned
No
TOP PICK
TOP PICK
November 28, 2012

5.75% bond maturing August 31/18. This is a convertible debenture. Company has fantastic interest coverage and very low debt.

Atrium Innovations. (ATB-T)
November 28, 2012

5.75% bond maturing August 31/18. This is a convertible debenture. Company has fantastic interest coverage and very low debt.

Joey Mack
Director, Fixed Income, ScotiaCapital
Price
$11.270
Owned
No
SELL
SELL
September 24, 2012

Vitamin Business. Likes long term demographics of vitamin and supplement business. Unfortunately a lot of business is in Europe and is hurting them. Thinks there is definitely better places to be. He sold his holdings.

Atrium Innovations. (ATB-T)
September 24, 2012

Vitamin Business. Likes long term demographics of vitamin and supplement business. Unfortunately a lot of business is in Europe and is hurting them. Thinks there is definitely better places to be. He sold his holdings.

Norman Levine
Managing Director, Portfolio Management Corp
Price
$10.720
Owned
No
PAST TOP PICK
PAST TOP PICK
July 27, 2011
(A Top Pick Aug 11/10. Down 7.38%.) Largest US manufacturer and one of the largest in Europe of high quality vitamins and other supplements. Also made acquisitions that have got them into the health store business. This is a buying opportunity.
(A Top Pick Aug 11/10. Down 7.38%.) Largest US manufacturer and one of the largest in Europe of high quality vitamins and other supplements. Also made acquisitions that have got them into the health store business. This is a buying opportunity.
Norman Levine
Managing Director, Portfolio Management Corp
Price
$15.040
Owned
Yes
DON'T BUY
DON'T BUY
March 15, 2011
If he bought it a month ago he would expect to sell it 5 years from now. Not really cheap. Would not buy it today and sell in 30 days. Would look at averaging the price.
If he bought it a month ago he would expect to sell it 5 years from now. Not really cheap. Would not buy it today and sell in 30 days. Would look at averaging the price.
Don Reed
President and Chief Executive Officer, Franklin Templeton Investments
Price
$15.330
Owned
Unknown
PAST TOP PICK
PAST TOP PICK
December 29, 2010
(A Top Pick Dec 23/09. Down 0.46%.) Canadian Based multinational consumer products company in the high quality vitamin supplements sold mostly though practitioners. Had to change a German product from a health supplement into a food additive, which has held back the sales. New product is selling well. Very low multiple. Good risk/reward. Still a Buy.
Atrium Innovations. (ATB-T)
December 29, 2010
(A Top Pick Dec 23/09. Down 0.46%.) Canadian Based multinational consumer products company in the high quality vitamin supplements sold mostly though practitioners. Had to change a German product from a health supplement into a food additive, which has held back the sales. New product is selling well. Very low multiple. Good risk/reward. Still a Buy.
Norman Levine
Managing Director, Portfolio Management Corp
Price
$15.220
Owned
Yes
SELL
SELL
December 6, 2010
In the nutri-ceuticals environment with drugs, health foods, etc. Hard to read how the market place is playing out in this sector. Prefers Paladin Labs (PLB-T) and would into this one instead.
In the nutri-ceuticals environment with drugs, health foods, etc. Hard to read how the market place is playing out in this sector. Prefers Paladin Labs (PLB-T) and would into this one instead.
Jason Donville
President & CEO, Donville Kent Asset Management
Price
$14.390
Owned
No
PAST TOP PICK
PAST TOP PICK
November 9, 2010
(Top Pick Nov 16/09, Down 2%) Nutrition business. Biggest maker of high quality supplements sold through practitioners. A German product changed classification from drug to food additive. They grow through acquisition and he expects them to do that next year.
(Top Pick Nov 16/09, Down 2%) Nutrition business. Biggest maker of high quality supplements sold through practitioners. A German product changed classification from drug to food additive. They grow through acquisition and he expects them to do that next year.
Norman Levine
Managing Director, Portfolio Management Corp
Price
$15.330
Owned
Yes
TOP PICK
TOP PICK
September 15, 2010
(A Top Pick Aug 19/09. Up 2.3%.) Premium nutritional products manufacturer. Trading around 8X earnings. Well managed. Had a couple of tough quarters with the weakness in the euro but that has turned around. Hoping to have 20% of the US market. Organic and acquisition growth.
Atrium Innovations. (ATB-T)
September 15, 2010
(A Top Pick Aug 19/09. Up 2.3%.) Premium nutritional products manufacturer. Trading around 8X earnings. Well managed. Had a couple of tough quarters with the weakness in the euro but that has turned around. Hoping to have 20% of the US market. Organic and acquisition growth.
Ara Nalbandian
Portfolio Manager, Highwater Capital Management
Price
$14.070
Owned
Yes
BUY
BUY
September 7, 2010
Natural products. Earnings 3 weeks ago were basically in line. Most of street were happy. One analyst lowered to a hold and there was a sell-off. He likes the outlook for ATB. Near term it has stalled out and given investors an opportunity here.
Atrium Innovations. (ATB-T)
September 7, 2010
Natural products. Earnings 3 weeks ago were basically in line. Most of street were happy. One analyst lowered to a hold and there was a sell-off. He likes the outlook for ATB. Near term it has stalled out and given investors an opportunity here.
Norman Levine
Managing Director, Portfolio Management Corp
Price
$14.170
Owned
Yes
TOP PICK
TOP PICK
August 11, 2010
Canadian-based multinational consumer company and largest player in high quality vitamins/supplements sold through practitioners. Market is growing 6%-7%. About half their business is out of Europe. Growth through acquisitions. Severely undervalued. Longer term play.
Canadian-based multinational consumer company and largest player in high quality vitamins/supplements sold through practitioners. Market is growing 6%-7%. About half their business is out of Europe. Growth through acquisitions. Severely undervalued. Longer term play.
Norman Levine
Managing Director, Portfolio Management Corp
Price
$16.250
Owned
Yes
PAST TOP PICK
PAST TOP PICK
June 23, 2010
(A Top Pick May 15/09. Up %.) (Think this should be Aug 19 and up 12.54%, not May 15 as BNN shows. Bill) Still likes this one.
(A Top Pick May 15/09. Up %.) (Think this should be Aug 19 and up 12.54%, not May 15 as BNN shows. Bill) Still likes this one.
Ara Nalbandian
Portfolio Manager, Highwater Capital Management
Price
$15.450
Owned
Yes
PAST TOP PICK
PAST TOP PICK
June 9, 2010
(Top Pick Jun 23/09, Up 13.55) But he sold out early and at a loss. Wouldn’t buy now. It’s making new lows.
(Top Pick Jun 23/09, Up 13.55) But he sold out early and at a loss. Wouldn’t buy now. It’s making new lows.
Jeff Parent B. Eng. FCSI CIM
VP & Portfolio Manager, Chief Investment Officer, Castlemoore Inc.
Price
$14.210
Owned
No
Showing 1 to 15 of 58 entries